GRANITE: Airsupra Effectiveness in the Real World

Trial Identifier:	D6930R00007
Sponsor:	AstraZeneca
Start Date:	July 2025
Primary Completion Date:	March 2026
Study Completion Date:	March 2026
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States, Delaware	Wilmington, Delaware, United States, 19803

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.